Universe Pharmaceuticals INC (UPC)
4.691
+0.026 (0.55%)
Inactive · Last trade price on Sep 23, 2026
UPC Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 17.74 | 17.86 | 23.02 | 32.31 | 40.14 | 47.98 |
Revenue Growth | -0.65% | -22.44% | -28.74% | -19.52% | -16.34% | 56.27% |
Gross Profit Gross Profit Growth | 6.48 | 6.3 | 6.07 | 10.32 | 21.89 | 25.33 |
Operating Income Operating Income Growth | -2.09 | -2.92 | -8.02 | -3.97 | -7.02 | 13.59 |
Net Income Net Income Growth | -1.94 | -3.67 | -8.73 | -6.58 | -7.91 | 11.32 |
Earnings Per Share EPS Growth | -3.45 | -8.06 | -626.96 | - | - | - |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 29.05 | 33.59 | 29.5 | 5.29 | 18.86 | 21.8 |
Total Debt Total Debt Growth | 9.55 | 9.26 | 7.99 | 5.48 | 3.94 | 4.33 |
Net Cash (Debt) Net Cash Growth | 19.5 | 24.34 | 21.5 | -0.2 | 14.92 | 17.47 |
Net Cash Growth | -19.88% | 13.17% | - | - | -14.57% | 135.67% |
Net Cash Per Share Net Cash Per Share Growth | 34.59 | 53.38 | 1544.79 | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -11.91 | -5.05 | -9.51 | 1.12 | -1.3 | -2.06 |
Capital Expenditures CapEx Growth | -0.48 | -0.27 | -0.25 | -0.04 | -0.09 | -13.53 |
Free Cash Flow Free Cash Flow Growth | -12.39 | -5.32 | -9.75 | 1.07 | -1.4 | -15.59 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 36.52% | 35.28% | 26.37% | 31.93% | 54.53% | 52.78% |
Operating Margin | -11.78% | -16.33% | -34.83% | -12.28% | -17.49% | 28.32% |
Pretax Margin | -10.95% | -20.56% | -35.27% | -13.39% | -17.67% | 28.51% |
Profit Margin | -10.95% | -20.56% | -37.90% | -20.37% | -19.70% | 23.59% |
FCF Margin | -69.85% | -29.78% | -42.36% | 3.32% | -3.48% | -32.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | 4.75 |
P/FCF Ratio | - | - | - | 3.23 | - | - |
PS Ratio | 1.33 | 0.13 | 0.25 | 0.11 | 0.31 | 1.12 |